Nymox Pharma (NYMX) Reports Q3 Loss of $0.02/Share

Nymox Pharma (NASDAQ: NYMX) reported Q3 EPS of ($0.02), versus ($0.03) reported last year. Revenue for the quarter came in at $81.1 thousand, versus $88.9 thousand reported last year.

For earnings history and earnings-related data on Nymox Pharma (NYMX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
• Hafnia Limited (HAFN) Tops Q2 EPS by 1c